BFS
MDT icon

Bradley Foster & Sargent’s Medtronic MDT Stock Holding History

Bradley Foster & Sargent’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.27M Sell
26,150
-316
-1% -$30.3K 0.04% 210
2025
Q4 		$2.54M Sell
26,466
-168
-0.6% -$16.3K 0.04% 196
2025
Q3 		$2.54M Buy
26,634
+164
+0.6% +$15.1K 0.04% 198
2025
Q2 		$2.31M Sell
26,470
-849
-3% -$72K 0.04% 207
2025
Q1 		$2.45M Buy
27,319
+2,465
+10% +$221K 0.04% 186
2024
Q4 		$1.99M Buy
24,854
+2,294
+10% +$199K 0.03% 206
2024
Q3 		$2.03M Sell
22,560
-2,714
-11% -$228K 0.03% 199
2024
Q2 		$1.99M Sell
25,274
-1,834
-7% -$150K 0.04% 196
2024
Q1 		$2.36M Buy
27,108
+77
+0.3% +$6.57K 0.04% 194
2023
Q4 		$2.23M Buy
27,031
+6,906
+34% +$526K 0.04% 194
2023
Q3 		$1.77M Hold
20,125
– – 0.04% 213
2023
Q2 		$1.77M Buy
20,125
+2,810
+16% +$242K 0.04% 213
2023
Q1 		$1.4M Buy
17,315
+1,485
+9% +$121K 0.03% 214
2022
Q4 		$1.23M Sell
15,830
-132
-0.8% -$10.7K 0.03% 227
2022
Q3 		$1.29M Sell
15,962
-147
-0.9% -$13.2K 0.04% 204
2022
Q2 		$1.45M Sell
16,109
-1,257
-7% -$127K 0.04% 205
2022
Q1 		$1.93M Sell
17,366
-176,122
-91% -$18.6M 0.04% 203
2021
Q4 		$20M Sell
193,488
-20,382
-10% -$2.36M 0.42% 65
2021
Q3 		$26.8M Buy
213,870
+2,564
+1% +$332K 0.63% 48
2021
Q2 		$26.2M Buy
211,306
+6,946
+3% +$872K 0.61% 50
2021
Q1 		$24.1M Buy
204,360
+186,246
+1,028% +$21.8M 0.61% 51
2020
Q4 		$2.12M Buy
18,114
+940
+5% +$103K 0.06% 164
2020
Q3 		$1.78M Buy
+17,174
New +$1.72M 0.05% 162
2020
Q1 		$1.39M Sell
15,443
-1,357
-8% -$144K 0.06% 161
2019
Q4 		$1.91M Buy
16,800
+2,421
+17% +$266K 0.06% 169
2019
Q3 		$1.56M Buy
14,379
+110
+0.8% +$11.5K 0.05% 184
2019
Q2 		$1.39M Sell
14,269
-127
-0.9% -$11.6K 0.05% 189
2019
Q1 		$1.31M Sell
14,396
-149
-1% -$13.3K 0.05% 191
2018
Q4 		$1.32M Sell
14,545
-46
-0.3% -$4.3K 0.05% 182
2018
Q3 		$1.44M Sell
14,591
-39
-0.3% -$3.61K 0.05% 195
2018
Q2 		$1.25M Buy
14,630
+263
+2% +$22K 0.04% 208
2018
Q1 		$1.15M Sell
14,367
-5
-0% -$412 0.04% 210
2017
Q4 		$1.16M Sell
14,372
-1,087
-7% -$87.1K 0.04% 207
2017
Q3 		$1.2M Sell
15,459
-643
-4% -$53.4K 0.05% 197
2017
Q2 		$1.43M Sell
16,102
-49,699
-76% -$4.19M 0.06% 182
2017
Q1 		$5.3M Sell
65,801
-39,250
-37% -$3.07M 0.21% 96
2016
Q4 		$7.48M Sell
105,051
-112,474
-52% -$8.84M 0.32% 87
2016
Q3 		$18.8M Sell
217,525
-7,880
-3% -$687K 0.82% 43
2016
Q2 		$19.6M Buy
225,405
+3,952
+2% +$320K 0.88% 44
2016
Q1 		$16.6M Buy
221,453
+163
+0.1% +$12.3K 0.77% 43
2015
Q4 		$17M Sell
221,290
-13,576
-6% -$1.02M 0.78% 44
2015
Q3 		$15.7M Sell
234,866
-2,371
-1% -$175K 0.77% 44
2015
Q2 		$17.6M Buy
237,237
+1,018
+0.4% +$77.8K 0.8% 42
2015
Q1 		$18.4M Buy
+236,219
New +$17.9M 0.84% 43
2014
Q4 		– Sell
-7,874
Closed -$488K – 358
2014
Q3 		$488K Buy
7,874
+2,230
+40% +$142K 0.02% 253
2014
Q2 		$360K Buy
5,644
+300
+6% +$18.2K 0.02% 273
2014
Q1 		$329K Sell
5,344
-676
-11% -$39.4K 0.02% 280
2013
Q4 		$345K Buy
6,020
+970
+19% +$55K 0.02% 282
2013
Q3 		$269K Buy
5,050
+795
+19% +$42.8K 0.02% 296
2013
Q2 		$219K Buy
+4,255
New +$210K 0.01% 301

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bradley Foster & Sargent's MDT Position: Q1 2026 in Review

Bradley Foster & Sargent reduced its Medtronic (MDT) stake by 1.2% in Q1 2026, selling an estimated $30.3K and leaving 26,150 shares worth $2.27M. The position accounts for 0.04% of the portfolio, ranked #210.

Bradley Foster & Sargent first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. The position peaked at $26.8M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Bradley Foster & Sargent held 26,150 shares of Medtronic worth $2.27M as of Q1 2026.
  • Bradley Foster & Sargent sold 316 Medtronic shares in Q1 2026, an estimated $30.3K.
  • Medtronic made up 0.04% of Bradley Foster & Sargent's portfolio in Q1 2026, its #210 holding.
  • Bradley Foster & Sargent first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
  • Bradley Foster & Sargent's Medtronic position peaked at $26.8M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Bradley Foster & Sargent's 13F filing for Q1 2026, filed 15 May 2026.